SlideShare une entreprise Scribd logo
1  sur  1
Télécharger pour lire hors ligne
Fresenius Medical Care North America, Naturalyte and Granuflo Acid Concentrate
Recall Class: Class I
Date Recall Initiated: March 29, 2012
Product: Naturalyte and Granuflo Acid Concentrate
Serial numbers for Naturalyte Liquid Acid Concentrate range from:
08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5,
08-2231-2, 08-2251-0, 08-2301-3,08-2351-8, 08-3201-4, 08-3231-1, 08-3251-9,
08-3301-2, 08-4123-1, 08-4223-7, 08-4225-1, 08-4230- 2, 08-4231-0, 08-4323-5,
08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1, 13-3251-9,
13-4123-1, 13-4220-1, 13-4225-1, 13-4325-1
Serial numbers for Naturalyte GranuFlo (powder) Acid Concentrate range from:
OFD1201-3B, OFD1251-3B, OFD2123-3B, OFD2201-38, OFD2220-3B, OFD2223-3B,
OFD2225-3B, OFD2231-3 B, OFD2251-3B, OFD2301-3B, OFD2323-3 B, OFD2325-3B,
OFD3201-3B, OFD3231-3B, OFD3251-3B, OFD3301-3B
This concentrate was manufactured and distributed from January 2008 through June 2012.
Use: The Naturalyte and Granuflo Dry Acid Concentrate are used in the treatment of acute
and chronic renal failure during hemodialysis. The concentrate is formulated to be used
with a three-stream hemodialysis machine, which is calibrated for acid and bicarbonate
concentrates.
Recalling Firm:
Fresenius Medical Care North America
920 Winter Street
Waltham, MA 02451
Reason for Recall:
The manufacturer is cautioning clinicians to be aware of the concentration of acetate or
sodium diacetate (acetic acid plus acetate) contained in Fresenius' Naturalyte Liquid and
Granuflo Dry Acid Concentrate. Inappropriate prescription of these products can lead to a
high serum bicarbonate level in patients undergoing hemodialysis. This may contribute to
metabolic alkalosis, which is a significant risk factor associated with low blood pressure,
hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately
treated, may culminate in cardiopulmonary arrest. This product may cause serious adverse
health consequences, including death.
FDA has issued a general safety communication related to inappropriate prescription and
resultant alkali dosing errors in the dialysate concentrates used in hemodialysis.
Public Contact:
Consumers may contact the firm at 1-800-662-1237.
FDA District: New England District Office
FDA Comments:
On March 29, 2012, the firm sent an Urgent Product Notification to their clinics and
customers. This notification provided clinicians with prescribing information regarding the
Naturalyte Liquid and Granuflo Acid Concentrate.
Class I recalls are the most serious type of recall and involve situations in which there is a
reasonable probability that use of these products will cause serious adverse health
consequences or death.
Health care professionals and consumers may report adverse reactions or quality problems
they experienced using these products to MedWatch: The FDA Safety Information and
Adverse Event Reporting Program1
either online, by regular mail or by FAX.
Medical Devices
Home Medical Devices Medical Device Safety Medical Device Recalls

Contenu connexe

Tendances

Purple cow 2011 (ape)
Purple cow 2011 (ape)Purple cow 2011 (ape)
Purple cow 2011 (ape)mervinabagat
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Rose088
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 
Changing PMA or HDE Devices during COVID-19
Changing PMA or HDE Devices during COVID-19Changing PMA or HDE Devices during COVID-19
Changing PMA or HDE Devices during COVID-19EMMAIntl
 

Tendances (6)

Purple cow 2011 (ape)
Purple cow 2011 (ape)Purple cow 2011 (ape)
Purple cow 2011 (ape)
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
Changing PMA or HDE Devices during COVID-19
Changing PMA or HDE Devices during COVID-19Changing PMA or HDE Devices during COVID-19
Changing PMA or HDE Devices during COVID-19
 

Similaire à Fda granuflo-naturalyte-recall

Safety communications fda safety communication dialysate concentrates and ...
Safety communications   fda safety communication  dialysate concentrates and ...Safety communications   fda safety communication  dialysate concentrates and ...
Safety communications fda safety communication dialysate concentrates and ...Michael J. Evans
 
Safety Dat Sheet for Glue.pdf
Safety Dat Sheet for Glue.pdfSafety Dat Sheet for Glue.pdf
Safety Dat Sheet for Glue.pdfBasharAlAli5
 
MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)Encapsula NanoSciences
 
Setac asia pacific 2014 - pharmaceutical era [gm2]
Setac asia pacific 2014 - pharmaceutical era [gm2]Setac asia pacific 2014 - pharmaceutical era [gm2]
Setac asia pacific 2014 - pharmaceutical era [gm2]David Taylor
 
MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)Encapsula NanoSciences
 
A Rare Case Report on Chronic Kidney Disease and Hypervitaminosis D
A Rare Case Report on Chronic Kidney Disease and Hypervitaminosis DA Rare Case Report on Chronic Kidney Disease and Hypervitaminosis D
A Rare Case Report on Chronic Kidney Disease and Hypervitaminosis DPARUL UNIVERSITY
 
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...IMARC Group
 
January 2016 Recall Register
January 2016 Recall Register January 2016 Recall Register
January 2016 Recall Register Graeme Cross
 
March 2016 Recall Register
March 2016 Recall RegisterMarch 2016 Recall Register
March 2016 Recall RegisterGraeme Cross
 
RETINA COMPANY SHOWCASE- Aerie Pharmaceuticals
RETINA COMPANY SHOWCASE- Aerie PharmaceuticalsRETINA COMPANY SHOWCASE- Aerie Pharmaceuticals
RETINA COMPANY SHOWCASE- Aerie PharmaceuticalsHealthegy
 

Similaire à Fda granuflo-naturalyte-recall (20)

Safety communications fda safety communication dialysate concentrates and ...
Safety communications   fda safety communication  dialysate concentrates and ...Safety communications   fda safety communication  dialysate concentrates and ...
Safety communications fda safety communication dialysate concentrates and ...
 
EnviroTabs Safety data
EnviroTabs Safety dataEnviroTabs Safety data
EnviroTabs Safety data
 
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
 
Health Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand PirouziHealth Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand Pirouzi
 
Safety Dat Sheet for Glue.pdf
Safety Dat Sheet for Glue.pdfSafety Dat Sheet for Glue.pdf
Safety Dat Sheet for Glue.pdf
 
MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)
 
Setac asia pacific 2014 - pharmaceutical era [gm2]
Setac asia pacific 2014 - pharmaceutical era [gm2]Setac asia pacific 2014 - pharmaceutical era [gm2]
Setac asia pacific 2014 - pharmaceutical era [gm2]
 
ICE CREAM HACCP GUIDLINES
ICE CREAM HACCP GUIDLINESICE CREAM HACCP GUIDLINES
ICE CREAM HACCP GUIDLINES
 
MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)
 
Usfda
UsfdaUsfda
Usfda
 
A Rare Case Report on Chronic Kidney Disease and Hypervitaminosis D
A Rare Case Report on Chronic Kidney Disease and Hypervitaminosis DA Rare Case Report on Chronic Kidney Disease and Hypervitaminosis D
A Rare Case Report on Chronic Kidney Disease and Hypervitaminosis D
 
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
Global Nutraceuticals Market | Functional Food | Industry Analysis, Size and ...
 
Salt Reduction '
Salt Reduction 'Salt Reduction '
Salt Reduction '
 
MSDS CosmoMix-ACE
MSDS CosmoMix-ACE MSDS CosmoMix-ACE
MSDS CosmoMix-ACE
 
Medwatch and FAERS database
Medwatch and FAERS databaseMedwatch and FAERS database
Medwatch and FAERS database
 
January 2016 Recall Register
January 2016 Recall Register January 2016 Recall Register
January 2016 Recall Register
 
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
 
March 2016 Recall Register
March 2016 Recall RegisterMarch 2016 Recall Register
March 2016 Recall Register
 
Cardiac Toxicity
Cardiac ToxicityCardiac Toxicity
Cardiac Toxicity
 
RETINA COMPANY SHOWCASE- Aerie Pharmaceuticals
RETINA COMPANY SHOWCASE- Aerie PharmaceuticalsRETINA COMPANY SHOWCASE- Aerie Pharmaceuticals
RETINA COMPANY SHOWCASE- Aerie Pharmaceuticals
 

Plus de Michael J. Evans

Fresenius mdl scheduling order filed 7 29-2013
Fresenius mdl scheduling order filed 7 29-2013Fresenius mdl scheduling order filed 7 29-2013
Fresenius mdl scheduling order filed 7 29-2013Michael J. Evans
 
Dialysis Patients' Bill of Rights and Responsibilities - National Kidney Foun...
Dialysis Patients' Bill of Rights and Responsibilities - National Kidney Foun...Dialysis Patients' Bill of Rights and Responsibilities - National Kidney Foun...
Dialysis Patients' Bill of Rights and Responsibilities - National Kidney Foun...Michael J. Evans
 
Drug safety and availability fda drug safety communication fda investigati...
Drug safety and availability   fda drug safety communication  fda investigati...Drug safety and availability   fda drug safety communication  fda investigati...
Drug safety and availability fda drug safety communication fda investigati...Michael J. Evans
 
Drug safety and availability fda drug safety communication fda investigati...
Drug safety and availability   fda drug safety communication  fda investigati...Drug safety and availability   fda drug safety communication  fda investigati...
Drug safety and availability fda drug safety communication fda investigati...Michael J. Evans
 
Fda granuflo-naturalyte-recall
Fda granuflo-naturalyte-recallFda granuflo-naturalyte-recall
Fda granuflo-naturalyte-recallMichael J. Evans
 
Fda warning letter 3 5-2013 to dialysis drug maker and dialysis provider Fres...
Fda warning letter 3 5-2013 to dialysis drug maker and dialysis provider Fres...Fda warning letter 3 5-2013 to dialysis drug maker and dialysis provider Fres...
Fda warning letter 3 5-2013 to dialysis drug maker and dialysis provider Fres...Michael J. Evans
 
Bp settlement could pay you money how to file a bp settlement claim
Bp settlement could pay you money   how to file a bp settlement claimBp settlement could pay you money   how to file a bp settlement claim
Bp settlement could pay you money how to file a bp settlement claimMichael J. Evans
 
Fed rulecivilprocedure23classactions
Fed rulecivilprocedure23classactionsFed rulecivilprocedure23classactions
Fed rulecivilprocedure23classactionsMichael J. Evans
 
Joint motionforpreliminaryapprovalofbp settlementwithdeclofazariex1_4_18_2012
Joint motionforpreliminaryapprovalofbp settlementwithdeclofazariex1_4_18_2012Joint motionforpreliminaryapprovalofbp settlementwithdeclofazariex1_4_18_2012
Joint motionforpreliminaryapprovalofbp settlementwithdeclofazariex1_4_18_2012Michael J. Evans
 
Florida bp complaint4-20-2013
Florida bp complaint4-20-2013Florida bp complaint4-20-2013
Florida bp complaint4-20-2013Michael J. Evans
 
Bp settlement final_order_and_judgment_on_economic_class_settlement
Bp settlement final_order_and_judgment_on_economic_class_settlementBp settlement final_order_and_judgment_on_economic_class_settlement
Bp settlement final_order_and_judgment_on_economic_class_settlementMichael J. Evans
 
Bp settlement order_and_reasons_for_final_approval_of_bp_settlement
Bp settlement order_and_reasons_for_final_approval_of_bp_settlement Bp settlement order_and_reasons_for_final_approval_of_bp_settlement
Bp settlement order_and_reasons_for_final_approval_of_bp_settlement Michael J. Evans
 
Bp claims administrators_status_report_no_8
Bp claims administrators_status_report_no_8Bp claims administrators_status_report_no_8
Bp claims administrators_status_report_no_8Michael J. Evans
 
Bp settlement economic_detailed_notice
Bp settlement economic_detailed_noticeBp settlement economic_detailed_notice
Bp settlement economic_detailed_noticeMichael J. Evans
 
Bp settlement agreement_amended_5-2-2012
Bp settlement agreement_amended_5-2-2012Bp settlement agreement_amended_5-2-2012
Bp settlement agreement_amended_5-2-2012Michael J. Evans
 
Bp settlement declaration_cameron_azari_bp_settlement_notice_administrator_4_...
Bp settlement declaration_cameron_azari_bp_settlement_notice_administrator_4_...Bp settlement declaration_cameron_azari_bp_settlement_notice_administrator_4_...
Bp settlement declaration_cameron_azari_bp_settlement_notice_administrator_4_...Michael J. Evans
 

Plus de Michael J. Evans (16)

Fresenius mdl scheduling order filed 7 29-2013
Fresenius mdl scheduling order filed 7 29-2013Fresenius mdl scheduling order filed 7 29-2013
Fresenius mdl scheduling order filed 7 29-2013
 
Dialysis Patients' Bill of Rights and Responsibilities - National Kidney Foun...
Dialysis Patients' Bill of Rights and Responsibilities - National Kidney Foun...Dialysis Patients' Bill of Rights and Responsibilities - National Kidney Foun...
Dialysis Patients' Bill of Rights and Responsibilities - National Kidney Foun...
 
Drug safety and availability fda drug safety communication fda investigati...
Drug safety and availability   fda drug safety communication  fda investigati...Drug safety and availability   fda drug safety communication  fda investigati...
Drug safety and availability fda drug safety communication fda investigati...
 
Drug safety and availability fda drug safety communication fda investigati...
Drug safety and availability   fda drug safety communication  fda investigati...Drug safety and availability   fda drug safety communication  fda investigati...
Drug safety and availability fda drug safety communication fda investigati...
 
Fda granuflo-naturalyte-recall
Fda granuflo-naturalyte-recallFda granuflo-naturalyte-recall
Fda granuflo-naturalyte-recall
 
Fda warning letter 3 5-2013 to dialysis drug maker and dialysis provider Fres...
Fda warning letter 3 5-2013 to dialysis drug maker and dialysis provider Fres...Fda warning letter 3 5-2013 to dialysis drug maker and dialysis provider Fres...
Fda warning letter 3 5-2013 to dialysis drug maker and dialysis provider Fres...
 
Bp settlement could pay you money how to file a bp settlement claim
Bp settlement could pay you money   how to file a bp settlement claimBp settlement could pay you money   how to file a bp settlement claim
Bp settlement could pay you money how to file a bp settlement claim
 
Fed rulecivilprocedure23classactions
Fed rulecivilprocedure23classactionsFed rulecivilprocedure23classactions
Fed rulecivilprocedure23classactions
 
Joint motionforpreliminaryapprovalofbp settlementwithdeclofazariex1_4_18_2012
Joint motionforpreliminaryapprovalofbp settlementwithdeclofazariex1_4_18_2012Joint motionforpreliminaryapprovalofbp settlementwithdeclofazariex1_4_18_2012
Joint motionforpreliminaryapprovalofbp settlementwithdeclofazariex1_4_18_2012
 
Florida bp complaint4-20-2013
Florida bp complaint4-20-2013Florida bp complaint4-20-2013
Florida bp complaint4-20-2013
 
Bp settlement final_order_and_judgment_on_economic_class_settlement
Bp settlement final_order_and_judgment_on_economic_class_settlementBp settlement final_order_and_judgment_on_economic_class_settlement
Bp settlement final_order_and_judgment_on_economic_class_settlement
 
Bp settlement order_and_reasons_for_final_approval_of_bp_settlement
Bp settlement order_and_reasons_for_final_approval_of_bp_settlement Bp settlement order_and_reasons_for_final_approval_of_bp_settlement
Bp settlement order_and_reasons_for_final_approval_of_bp_settlement
 
Bp claims administrators_status_report_no_8
Bp claims administrators_status_report_no_8Bp claims administrators_status_report_no_8
Bp claims administrators_status_report_no_8
 
Bp settlement economic_detailed_notice
Bp settlement economic_detailed_noticeBp settlement economic_detailed_notice
Bp settlement economic_detailed_notice
 
Bp settlement agreement_amended_5-2-2012
Bp settlement agreement_amended_5-2-2012Bp settlement agreement_amended_5-2-2012
Bp settlement agreement_amended_5-2-2012
 
Bp settlement declaration_cameron_azari_bp_settlement_notice_administrator_4_...
Bp settlement declaration_cameron_azari_bp_settlement_notice_administrator_4_...Bp settlement declaration_cameron_azari_bp_settlement_notice_administrator_4_...
Bp settlement declaration_cameron_azari_bp_settlement_notice_administrator_4_...
 

Dernier

MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 

Dernier (20)

How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 

Fda granuflo-naturalyte-recall

  • 1. Fresenius Medical Care North America, Naturalyte and Granuflo Acid Concentrate Recall Class: Class I Date Recall Initiated: March 29, 2012 Product: Naturalyte and Granuflo Acid Concentrate Serial numbers for Naturalyte Liquid Acid Concentrate range from: 08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8, 08-3201-4, 08-3231-1, 08-3251-9, 08-3301-2, 08-4123-1, 08-4223-7, 08-4225-1, 08-4230- 2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1, 13-3251-9, 13-4123-1, 13-4220-1, 13-4225-1, 13-4325-1 Serial numbers for Naturalyte GranuFlo (powder) Acid Concentrate range from: OFD1201-3B, OFD1251-3B, OFD2123-3B, OFD2201-38, OFD2220-3B, OFD2223-3B, OFD2225-3B, OFD2231-3 B, OFD2251-3B, OFD2301-3B, OFD2323-3 B, OFD2325-3B, OFD3201-3B, OFD3231-3B, OFD3251-3B, OFD3301-3B This concentrate was manufactured and distributed from January 2008 through June 2012. Use: The Naturalyte and Granuflo Dry Acid Concentrate are used in the treatment of acute and chronic renal failure during hemodialysis. The concentrate is formulated to be used with a three-stream hemodialysis machine, which is calibrated for acid and bicarbonate concentrates. Recalling Firm: Fresenius Medical Care North America 920 Winter Street Waltham, MA 02451 Reason for Recall: The manufacturer is cautioning clinicians to be aware of the concentration of acetate or sodium diacetate (acetic acid plus acetate) contained in Fresenius' Naturalyte Liquid and Granuflo Dry Acid Concentrate. Inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis. This may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest. This product may cause serious adverse health consequences, including death. FDA has issued a general safety communication related to inappropriate prescription and resultant alkali dosing errors in the dialysate concentrates used in hemodialysis. Public Contact: Consumers may contact the firm at 1-800-662-1237. FDA District: New England District Office FDA Comments: On March 29, 2012, the firm sent an Urgent Product Notification to their clinics and customers. This notification provided clinicians with prescribing information regarding the Naturalyte Liquid and Granuflo Acid Concentrate. Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death. Health care professionals and consumers may report adverse reactions or quality problems they experienced using these products to MedWatch: The FDA Safety Information and Adverse Event Reporting Program1 either online, by regular mail or by FAX. Medical Devices Home Medical Devices Medical Device Safety Medical Device Recalls